URMC Geneticists Verify Cholesterol-Cancer Link
9/17/2012
University of Rochester Medical Center scientists discovered new genetic evidence linking cholesterol and cancer, raising the possibility that cholesterol medications could be useful in the future for cancer prevention or to augment existing cancer treatment...
Researchers at Moffitt Cancer Center and colleagues have discovered that changes in the physical characteristics of the effector memory regulatory T cell can predict the progression risk of myelodysplastic syndromes (MDS) to acute myeloid leukemia. The finding could improve prognostication for patients with MDS and better inform therapeutic decision making...
Cell Death Mystery Yields New Suspect For Cancer Drug Development - CIB1
9/17/2012
A mysterious form of cell death, coded in proteins and enzymes, led to a discovery by UNC researchers uncovering a prime suspect for new cancer drug development. CIB1 is a protein discovered in the lab of Leslie Parise, PhD , professor and chair of the department of biochemistry at the University of North Carolina at Chapel Hill...
Effects Of Stopping Alcohol Consumption On Subsequent Risk Of Esophageal Cancer
9/17/2012
Cancer of the oesophagus is becoming more common in Europe and North America. Around 7,800 people in the UK are diagnosed each year. The exact causes of this cancer aren't fully understood. It appears to be more common in people who have long-term acid reflux (backflow of stomach acid into the oesophagus)...
Under-Twisted DNA Origami Delivers Cancer Drugs To Tumors
9/17/2012
Scientists at Karolinska Institutet in Sweden describe in a new study how so-called DNA origami can enhance the effect of certain cytostatics used in the treatment of cancer. With the aid of modern nanotechnology, scientists can target drugs direct to the tumour while leaving surrounding healthy tissue untouched...
UMass Amherst Chemists Develop Nose-Like Sensor Array To 'Smell' Cancer Diagnoses
9/17/2012
In the fight against cancer, knowing the enemy's exact identity is crucial for diagnosis and treatment, especially in metastatic cancers, those that spread between organs and tissues. Now chemists led by Vincent Rotello at the University of Massachusetts Amherst have developed a rapid, sensitive way to detect microscopic levels of many different metastatic cell types in living tissue...
Cloned Receptor Paves Way For New Breast And Prostate Cancer Treatment
9/17/2012
Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability to specifically kill prostate and breast cancer cells. The study was published last week in PNAS...
Type 2 Diabetes Linked To Breast Cancer Risk
9/15/2012
Having type 2 diabetes appears to give post-menopausal women a 27% higher risk of developing breast cancer, according to a new study published in the British Journal of Cancer this week. While the link may be indirectly associated with being overweight, a known risk factor for both diseases, the researchers don't rule out that type 2 diabetes may affect breast cancer risk directly...
Chest X-Rays On Young Women With Faulty Genes Increase Breast Cancer Risk
9/14/2012
Women with faults in BRCA genes are at higher risk for breast cancer if they receive chest X rays before they are 30, according to a study led by the University of Cambridge that was published online in BMJ on 6 September...
Eliminating Alcohol May Reduce The Risk Of Esophageal Cancer
9/14/2012
Low levels of alcohol intake have been found to decrease risk of esophageal cancer. The exact cause of esophageal cancer is not known. Previous research has stated it is more common in people with acid-reflux, and people with acid-reflux tend to be obese. Other factors can also increase the risk such as: Gender. It is more common in men than women. Age...